1
|
Knudsen KA and Wheelock MJ: Cadherins and
the mammary gland. J Cell Biochem. 95:488–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Andrews JL, Kim AC and Hens JR: The role
ad function of cadherins in the mammary gland. Breast Cancer Res.
14:2032012. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Farina AK, Bong YS, Feltes CM and Byers
SW: Post-transcriptional regulation of cadherin-11 expression by
GSK-3 and beta-catenin in prostate and breast cancer cells. PLoS
One. 4:e47972009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Albergaria A, Ribeiro AS, Vieira AF, Sousa
B, Nobre AR, Seruca R, Schmitt FC and Paredes J: P-cadherin role in
normal breast development and cancer. Int J Dev Biol. 55:811–822.
2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Tamura D, Hiraga T, Myoui A, Yoshikawa H
and Yoneda T: Cadherin-11-mediated interactions with bone marrow
stromal/osteoblastic cells support selective colonization of breast
cancer cells in bone. Int J Oncol. 33:17–24. 2008.PubMed/NCBI
|
6
|
Pishvaian MJ, Feltes CM, Thompson P,
Bussemakers MJ, Schalken JA and Byers SW: Cadherin-11 is expressed
in invasive breast cancer cell lines. Cancer Res. 59:947–952.
1999.PubMed/NCBI
|
7
|
Berx G and van Roy F: Involvement of
members of the cadherin superfamily in cancer. Cold Spring Harb
Perspect Biol. 1:a0031292009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Maeda M, Johnson KR and Wheelock MJ:
Cadherin switching: Essential for behavioral but not morphological
changes during epithelium-to-mesenchyme transition. J Cell Sci.
118:873–887. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Lee DM, Kiener HP, Agarwal SK, Noss EH,
Watts GF, Chisaka O, Takeichi M and Brenner MB: Cadherin-11 in
synovial lining formation and pathology in arthritis. Science.
315:1006–1010. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Huang CF, Lira C, Chu K, Bilen MA, Lee YC,
Ye X, Kim SM, Ortiz A, Wu FL, Logothetis CJ, et al: Cadherin-11
increases migration and invasion of prostate cancer cells and
enhances their interaction with osteoblasts. Cancer Res.
70:4580–4589. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Nieto MA: Epithelial-mesenchymal
transitions in development and disease: Old views and new
perspectives. Int J Dev Biol. 53:1541–1547. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chao YL, Shepard CR and Wells A: Breast
carcinoma cells re-express E-cadherin during mesenchymal to
epithelial reverting transition. Mol Cancer. 9:1792010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Clevers H and Nusse R: Wnt/ß-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Dubois-Marshall S, Thomas JS, Faratian D,
Harrison DJ and Katz E: Two possible mechanisms of epithelial to
mesenchymal transition in invasive ductal breast cancer. Clin Exp
Metastasis. 28:811–818. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Aceto N, Toner M, Maheswaran S and Haber
D: En route to metastasis: Circulating tumor cell clusters and
epithelial-to-mesenchymal transition. Trends in Cancer. 1:44–52.
2015. View Article : Google Scholar
|
18
|
Satcher RL, Pan T, Cheng CJ, Lee YC, Lin
SC, Yu G, Li X, Hoang AG, Tamboli P, Jonasch E, et al: Cadherin-11
in renal cell carcinoma bone metastasis. PLoS One. 9:e898802014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Li Y, Chao F, Huang B, Liu D, Kim J and
Huang S: HOXC8 promotes breast tumorigenesis by transcriptionally
facilitating cadherin-11 expression. Oncotarget. 5:2596–2607. 2014.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Alimperti S and Andreadis ST: CDH2 and
CDH11 act as regulators of stem cell fate decisions. Stem Cell Res.
14:270–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Assefnia S, Dakshanamurthy S, Auvil JM
Guidry, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW,
Brown ML, Shapiro L, et al: Cadherin-11 in poor prognosis
malignancies and rheumatoid arthritis: Common target, common
therapies. Oncotarget. 5:1458–1474. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Dakshanamurthy S, Issa NT, Assefnia S,
Seshasayee A, Peters OJ, Madhavan S, Uren A, Brown ML and Byers SW:
Predicting new indications for approved drugs using a
proteochemometric method. J Med Chem. 55:6832–6848. 2012.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Remmele W and Schicketanz KH:
Immunohistochemical determination of estrogen and progesterone
receptor content in human breast cancer. Computer-assisted image
analysis (QIC score) vs. subjective grading (IRS). Pathol Res
Pract. 189:862–866. 1993. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hicks DG and Schiffhauer L: Standardized
assessment of the HER2 status in breast cancer by
immunohistochemistry. Lab Med. 42:459–467. 2011. View Article : Google Scholar
|
25
|
Savci-Heijink CD, Halfwerk H, Hooijer GK,
Horlings HM, Wesseling J and van de Vijver MJ: Retrospective
analysis of metastatic behaviour of breast cancer subtypes. Breast
Cancer Res Treat. 150:547–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Salmen J, Neugebauer J, Fasching PA,
Haeberle L, Huober J, Wöckel A, Rauh C, Schuetz F, Weissenbacher T,
Kost B, et al: Pooled analysis of the prognostic relevance of
progesterone receptor status in five German cohort studies. Breast
Cancer Res Treat. 148:143–151. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sun JY, Wu SG, Li FY, Lin HX and He ZY:
Progesterone receptor loss identifies hormone receptor-positive and
HER2-negative breast cancer subgroups at higher risk of relapse: A
retrospective cohort study. Onco Targets Ther. 9:1707–1713.
2016.PubMed/NCBI
|
28
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin superfamily members in cancer. Nat Rev Cancer.
14:121–134. 2014. View
Article : Google Scholar : PubMed/NCBI
|